The Application of Indocyanine Green in Guiding Prostate Cancer Treatment

Overview

Journal Asian J Urol

Specialty Urology

Date 2023 Feb 1

PMID 36721695

Authors

Donghua Xie

Di Gu

Ming Lei

Cong Cai

Wen Zhong

Defeng Qi

Wenqi Wu

Guohua Zeng

Yongda Liu

Affiliations

Soon will be listed here.

Abstract

Objective: Indocyanine green (ICG) with near-infrared fluorescence absorption is approved by the United States Food and Drug Administration for clinical applications in angiography, blood flow evaluation, and liver function assessment. It has strong optical absorption in the near-infrared region, where light can penetrate deepest into biological tissue. We sought to review its value in guiding prostate cancer treatment.

Methods: All related literature at PubMed from January 2000 to December 2020 were reviewed.

Results: Multiple preclinical studies have demonstrated the usefulness of ICG in identifying prostate cancer by using different engineering techniques. Clinical studies have demonstrated the usefulness of ICG in guiding sentinel node dissection during radical prostatectomy, and possible better preservation of neurovascular bundle by identifying landmark prostatic arteries. New techniques such as adding fluorescein in additional to ICG were tested in a limited number of patients with encouraging result. In addition, the use of the ICG was shown to be safe. Even though there are encouraging results, it does not carry sufficient sensitivity and specificity in replacing extended pelvic lymph node dissection during radical prostatectomy.

Conclusion: Multiple preclinical and clinical studies have shown the usefulness of ICG in identifying and guiding treatment for prostate cancer. Larger randomized prospective studies are warranted to further test its usefulness and find new modified approaches.

Citing Articles

Progress of fluorescence imaging in lymph node dissection surgery for prostate and bladder cancer.

Xu M, Li P, Wei J, Yan P, Zhang Y, Guo X Front Oncol. 2024; 14:1395284.

PMID: 39429471 PMC: 11486700. DOI: 10.3389/fonc.2024.1395284.

New actors in prostate cancer surgical theatre: are we sharpening the eye with optical imaging?.

Gelardi F, Antunovic L Eur J Nucl Med Mol Imaging. 2023; 51(10):2929-2930.

PMID: 37500792 DOI: 10.1007/s00259-023-06366-2.

Performance of indocyanine green in sentinel lymph node mapping and lymph node metastasis in penile cancer: systematic review, meta-analysis, and single-center experience.

Zhang R, Zhang Y, Dong S, Pang K, Yang X, Wei X World J Urol. 2023; 41(9):2319-2326.

PMID: 37419973 DOI: 10.1007/s00345-023-04485-x.

Diagnosis and Treatment of Post-Prostatectomy Lymphedema: What's New?.

Bianchi L, Irmici G, Ce M, DAscoli E, Della Pepa G, Di Vita F Curr Oncol. 2023; 30(5):4512-4526.

PMID: 37232799 PMC: 10217297. DOI: 10.3390/curroncol30050341.

A Curcumin-BODIPY Dyad and Its Silica Hybrid as NIR Bioimaging Probes.

Gangemi C, Salerno T, Barattucci A, Cucinotta F, Bonaccorsi P, Calabrese G Int J Mol Sci. 2022; 23(17).

PMID: 36076937 PMC: 9455722. DOI: 10.3390/ijms23179542.

References

Sano K, Nakajima T, Ali T, Bartlett D, Wu A, Kim I . Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging. J Biomed Opt. 2013; 18(10):101304. PMC: 3677842. DOI: 10.1117/1.JBO.18.10.101304. View

Ranjan A, Zeglam K, Mukerjee A, Thamake S, Vishwanatha J . A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging. Nanotechnology. 2011; 22(29):295104. DOI: 10.1088/0957-4484/22/29/295104. View

van Willigen D, van den Berg N, Buckle T, KleinJan G, Hardwick J, van der Poel H . Multispectral fluorescence guided surgery; a feasibility study in a phantom using a clinical-grade laparoscopic camera system. Am J Nucl Med Mol Imaging. 2017; 7(3):138-147. PMC: 5511123. View

Kim G, Huang S, Day K, ODonnell M, Agayan R, Day M . Indocyanine-green-embedded PEBBLEs as a contrast agent for photoacoustic imaging. J Biomed Opt. 2007; 12(4):044020. DOI: 10.1117/1.2771530. View

Shimbo M, Endo F, Matsushita K, Hattori K . Impact of indocyanine green-guided extended pelvic lymph node dissection during robot-assisted radical prostatectomy. Int J Urol. 2020; 27(10):845-850. DOI: 10.1111/iju.14306. View

Jeschke S, Lusuardi L, Myatt A, Hruby S, Pirich C, Janetschek G . Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging. Urology. 2012; 80(5):1080-6. DOI: 10.1016/j.urology.2012.05.050. View

van Oosterom M, Meershoek P, Welling M, Pinto F, Matthies P, Simon H . Extending the Hybrid Surgical Guidance Concept With Freehand Fluorescence Tomography. IEEE Trans Med Imaging. 2019; 39(1):226-235. DOI: 10.1109/TMI.2019.2924254. View

Miki J, Yanagisawa T, Tsuzuki S, Mori K, Urabe F, Kayano S . Anatomical localization and clinical impact of sentinel lymph nodes based on patterns of pelvic lymphatic drainage in clinically localized prostate cancer. Prostate. 2018; 78(6):419-425. DOI: 10.1002/pros.23486. View

Jacquart A, Keramidas M, Vollaire J, Boisgard R, Pottier G, Rustique E . LipImage™ 815: novel dye-loaded lipid nanoparticles for long-term and sensitive in vivo near-infrared fluorescence imaging. J Biomed Opt. 2013; 18(10):101311. DOI: 10.1117/1.JBO.18.10.101311. View

10.

Ramirez-Backhaus M, Mira Moreno A, Ferrer A, Fons A, Casanova J, Solsona Narbon E . Indocyanine Green Guided Pelvic Lymph Node Dissection: An Efficient Technique to Classify the Lymph Node Status of Patients with Prostate Cancer Who Underwent Radical Prostatectomy. J Urol. 2016; 196(5):1429-1435. DOI: 10.1016/j.juro.2016.05.087. View

11.

KleinJan G, Bunschoten A, van den Berg N, Olmos R, Klop W, Horenblas S . Fluorescence guided surgery and tracer-dose, fact or fiction?. Eur J Nucl Med Mol Imaging. 2016; 43(10):1857-67. PMC: 4969335. DOI: 10.1007/s00259-016-3372-y. View

12.

van der Poel H, Buckle T, Brouwer O, Olmos R, van Leeuwen F . Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol. 2011; 60(4):826-33. DOI: 10.1016/j.eururo.2011.03.024. View

13.

Yuen D, Gonder J, Proulx A, Liu H, Hutnik C . Comparison of the in vitro safety of intraocular dyes using two retinal cell lines: a focus on brilliant blue G and indocyanine green. Am J Ophthalmol. 2008; 147(2):251-259.e2. DOI: 10.1016/j.ajo.2008.08.031. View

14.

Mangano M, De Gobbi A, Beniamin F, Lamon C, Ciaccia M, Maccatrozzo L . Robot-assisted nerve-sparing radical prostatectomy using near-infrared fluorescence technology and indocyanine green: initial experience. Urologia. 2017; 85(1):29-31. DOI: 10.5301/uj.5000244. View

15.

Reichel D, Tripathi M, Butte P, Saouaf R, Perez J . Tumor-Activatable Clinical Nanoprobe for Cancer Imaging. Nanotheranostics. 2019; 3(2):196-211. PMC: 6536784. DOI: 10.7150/ntno.34921. View

16.

Ruhi M, Ak A, Gulsoy M . Dose-dependent photochemical/photothermal toxicity of indocyanine green-based therapy on three different cancer cell lines. Photodiagnosis Photodyn Ther. 2018; 21:334-343. DOI: 10.1016/j.pdpdt.2018.01.008. View

17.

Heck M, Retz M, Bandur M, Souchay M, Vitzthum E, Weirich G . Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study. Eur Urol. 2013; 66(2):222-9. DOI: 10.1016/j.eururo.2013.02.007. View

18.

Manny T, Patel M, Hemal A . Fluorescence-enhanced robotic radical prostatectomy using real-time lymphangiography and tissue marking with percutaneous injection of unconjugated indocyanine green: the initial clinical experience in 50 patients. Eur Urol. 2013; 65(6):1162-8. DOI: 10.1016/j.eururo.2013.11.017. View

19.

Hruby S, Englberger C, Lusuardi L, Schatz T, Kunit T, Abdel-Aal A . Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer. J Urol. 2015; 194(2):357-63. DOI: 10.1016/j.juro.2015.03.127. View

20.

Ji C, Yuan A, Xu L, Zhang F, Zhang S, Zhao X . Activatable Photodynamic Therapy for Prostate Cancer by NIR Dye/Photosensitizer Loaded Albumin Nanoparticles. J Biomed Nanotechnol. 2019; 15(2):311-318. DOI: 10.1166/jbn.2019.2685. View